YOU COULD SAY it’s been the best of times and the worst of times for Facebook Inc. This summer the social media platform’s number of monthly users reached 2 billion. That’s more than one-fourth of the world population, and Facebook has achieved that global reach while still off limits for more than a billion Chinese. More than half of Facebook users log in every day; in the U.S., one out of every five internet page views takes place on Facebook. The company is currently valued at $435 billion.
This success has come despite what should have been a truly dreadful year for the company’s image. Rapes, murders, and suicides have been live-streamed on Facebook. And at least some of those atrocities may have been provoked by the unparalleled opportunity Facebook offers to sociopaths and exhibitionists. In addition, in the past year Facebook was guilty of helping disseminate false information that helped elect Donald Trump. The social network has also been widely named as a major contributor to our increasingly toxic political culture, in which citizens never have to face facts that might contradict their prejudices. A 2016 study from the University of Pittsburgh even found an association between social media use, including Facebook, and depression among young adults.
ARE CLEVERLY branded fishing hats, stuffed animals, and fancy dinners to blame for the raging opioid and heroin epidemic in the U.S.?
Most of us know the breathtaking scope of that epidemic. People are dying of overdoses at a higher rate than ever in our history—nearly 80 deaths every single day. Four of every five heroin users trace their addiction back to prescription painkillers or opioids.
Less well known is the unethical corporate sales and lobbying blitz that helped trigger the epidemic. During the two decades when addiction rates climbed to unprecedented numbers, multiple pharmaceutical companies spent billions of dollars pushing physicians and patients into a downward spiral of painkiller overprescription and abuse.
Corporate painkiller promotions included dinners and junkets for physicians and direct outreach to patients. One company even funded a “pain guide” that cheerfully promoted the life-changing benefits of opioids while citing multiple “disadvantages” of over-the-counter medications such as ibuprofen. At the same time, the industry was using insider ties to rewrite the medical guidelines that justified the rash of prescriptions.
The efforts paid off. In 2010 alone, physicians wrote 254 million prescriptions for opioids, and pharmaceutical corporations raked in $11 billion in opioid sales.
Multiple companies are culpable, but the most high-profile effort was Purdue Pharma’s promotion of OxyContin. Purdue’s marketing centered on the claim, embossed on its complementary fishing hats and plush toys, that each dose of the drug provided 12 hours of relief. The lengthy duration was the factor that distinguished OxyContin from other, cheaper alternatives.
Unfortunately, for many patients, the drug’s effects did not actually last that long, according to multiple clinical trials, patient experiences, and physician reports. When OxyContin’s effects wore off before the next scheduled dose, it created desperate patients—and what one neuropharmacologist calls “the perfect recipe for addiction.” In one New York county, for example, between 1996 and 2011 opioid pill use increased 1,136 percent and heroin use rose 425 percent.
As you are reading this, the Congressional Joint Select Committee on Deficit Reduction (a.k.a. The Super Committee) is making choices about who and what our nation will protect.
Will we protect the wealthiest 2 percent by preserving $690 billion in Bush era tax cuts?
Or will we protect children by preserving $650 billion in special education, student aid, and assistance to low-income schools?
Will we protect corporations by preserving $97.5 billion in subsidies for big business or will we protect families by preserving $98 billion in Head Start and child care programs?
We have 32 days left to remind Congress that, "Oppressing the poor in order to enrich oneself, and giving to the rich, will lead only to loss" (Proverbs 22:16).